"Franciscus Gasthuis & Vlietland staat voor top zorg, dicht bij huis. Met ruim 4.600 medewerkers en 250 artsen staan wij graag voor u klaar. Toen, nu én in de toekomst."

During the past decade, Sint Franciscus Gasthuis conducted 68 clinical trials. In the 10-year time frame, 68 clinical trials started and 12 clinical trials were completed, i.e. on average, 17.6% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 5 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sint Franciscus Gasthuis" #1 sponsor was "Erasmus Medical Center" with 10 trials, followed by "The Netherlands Cancer Institute" with 10 trials sponsored, "Radboud University Medical Center" with 6 trials sponsored, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 5 trials sponsored and "Boehringer Ingelheim" with 5 trials sponsored. Other sponsors include 67 different institutions and companies that sponsored additional 49 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sint Franciscus Gasthuis" #1 collaborator was "Erasmus Medical Center" with 9 trials as a collaborator, "ZonMw: The Netherlands Organisation for Health Research and Development" with 8 trials as a collaborator, "Roche Pharma AG" with 5 trials as a collaborator, "UMC Utrecht" with 5 trials as a collaborator and "Bayer" with 4 trials as a collaborator. Other collaborators include 127 different institutions and companies that were collaborators in the rest 108 trials.

According to Clinical.Site data, the most researched conditions in "Sint Franciscus Gasthuis" are "Breast Cancer" (7 trials), "Atrial Fibrillation" (4 trials), "Colorectal Cancer" (4 trials), "Crohn Disease" (4 trials) and "Cardiovascular Disease" (3 trials). Many other conditions were trialed in "Sint Franciscus Gasthuis" in a lesser frequency.

Most popular intervention types in "Sint Franciscus Gasthuis" are "Drug" (69 trials), "Other" (17 trials), "Procedure" (14 trials), "Biological" (4 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Bevacizumab" (3 trials), "Atrasentan" (2 trials), "Blood sample" (2 trials) and "Cabazitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sint Franciscus Gasthuis" are 85 trials for "All" genders, 12 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are 41 active trials in "Sint Franciscus Gasthuis". 1 are not yet recruiting, 22 are recruiting, 16 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 48 completed trials in Sint Franciscus Gasthuis, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Sint Franciscus Gasthuis, 2 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 16 trials that are defined as “Not Applicable".